icon-folder.gif   Conference Reports for NATAP  
 
  53rd ICAAC Interscience Conference on
Antimicrobial Agents and Chemotherapy
September 10-13, 2013, Denver CO
Back grey_arrow_rt.gif
 
 
 
Simplification to Abacavir/Lamivudine (ABC/3TC) + Atazanavir (ATV) From Tenofovir/Emtricitabine (TDF/FTC) + ATV/Ritonavir (r) Maintains Viral Suppression and Improves Bone Biomarkers: 48 Week ASSURE
 
 
  Study Results
 
Reported by Jules Levin
53rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September
10-13, 2013; Denver, CO
 
D Wohl,1 L Bhatti,2 CB Small,3 H Edelstein,4 HH Zhao,5 DA Margolis,5 LL Ross,6 MS Shaefer,6 for the ASSURE Team
1AIDS Clinical Trials Unit, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 2AIDS Healthcare Foundation, Beverly Hills, CA, USA; 3New York Medical College, Valhalla, NY, USA; 4Alameda County Medical Center, Oakland, CA, USA; 5GlaxoSmithKline, Research Triangle Park, NC, USA; 6ViiV Healthcare, Research Triangle Park, NC, USA

ICAAC1.gif

ICAAC2.gif

ICAAC3.gif

ICAAC4.gif

ICAAC5.gif

ICAAC6.gif

ICAAC7.gif